Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 488 for center for individualized medicine

Edit search filters
  1. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL)

    Rochester, MN

  2. Pediatric MSC-AFP Sub-study for Crohn's Fistula

    Rochester, MN

  3. Study Evaluating the Side Effects of Bone Marrow-Derived Stem Cells When Injected Into the Facet Joints for the Treatment of Painful Arthropathies

    Jacksonville, FL

  4. Primary Hyperoxaluria Mutation Genotyping/Phenotyping

    Rochester, MN

  5. Senescence in Chronic Kidney Disease

    Rochester, MN

  6. Study of Cryoablation for Metastatic Lung Tumors

    Rochester, MN

  7. Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas

    Rochester, MN

  8. Phase 1 Crohn's Pediatric Sub-study of MSC AFP

    Rochester, MN

  9. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer

    Rochester, MN

  10. A Study to Evaluate Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis

    Rochester, MN

.

Mayo Clinic Footer